Research interests include Cancer Cells and Metastasis, Histone Deacetylase Inhibitors Research, Cancer Genomics and Diagnostics, and Lymphoma Diagnosis and Treatment.
A Phase I, Open-Label Study of Siltuximab, an Anti–IL-6 Monoclonal Antibody, in Patients with B-cell Non-Hodgkin Lymphoma, Multiple Myeloma, or Castleman Disease
Clinical Cancer Research2013cited by 203position: middledoi